Neuronostics announces Microsoft collaboration

Neuronostics Ltd, today announces that it has been selected by Microsoft for a new programme designed to help startups get off the ground. Microsoft for Startups will provide up to $500 million worth of… [Read More]

Epilepsy diagnostic specialist Neuronostics Ltd, appoints Dr. Wes Woldman as Scientific Director.

Neuronostics, the developer of #BioEP, the revolutionary epilepsy assessment tool, announces the appointment of Dr. Wessel (Wes) Woldman as Scientific Director.  Dr. Woldman, will lead and manage application research and development of… [Read More]

Neuronostics announces first new recruit to its senior management team

Neuronostics Ltd, developer of the revolutionary seizure susceptibility assessment technology called #BioEP, announces the appointment of Ross Parkman as Technical & Operations Director.  Mr Parkman, who previously 15 years at IT solutions… [Read More]

Neuronostics secures funding from Innovate UK and University of Exeter to accelerate development of #BioEP

Neuronostics Ltd, announces that in conjunction with the University of Exeter, it has been awarded £504,000 grant funding to accelerate the development of its potentially revolutionary seizure susceptibility technology called #BioEP. The… [Read More]